🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer i...
Status
Recruiting
Location
City of Hope National Medical Center /ID# 273132
Start Date
2025-06-30
Trial ID
NCT06892522
The goal of this clinical trial is to find out how well a combination of tw...
Status
Recruiting
Location
National University Hospital (NUH)
Start Date
2024-11-26
Trial ID
NCT06645678
Treatments Being Tested
The purpose of this study is to determine the recommended dose and schedule...
Status
Terminated
Location
Local Institution - 0033
Start Date
2024-02-27
Trial ID
NCT06163898
Treatments Being Tested
Multiple myeloma (MM) is the second most common hematologic malignancy with...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-02
Trial ID
NCT06050512
Treatments Being Tested
This phase Ib trial tests the safety, side effects, and best dose of CC-924...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2023-12-21
Trial ID
NCT05981209
This phase I trial studies the safety, side effects, best dose and effectiv...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-04-09
Trial ID
NCT06048250
The purpose of this study is to develop taste profiles of iberdomide and me...
Status
Completed
Location
Local Institution - 0001
Start Date
2022-09-30
Trial ID
NCT05539976
The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) wi...
Status
Active Not Recruiting
Location
Local Institution - 0046
Start Date
2023-01-10
Trial ID
NCT05552976
Treatments Being Tested
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
The purpose of this study is to evaluate the safety and preliminary efficac...
Status
Active Not Recruiting
Location
Local Institution - 119
Start Date
2019-09-30
Trial ID
NCT03989414
Treatments Being Tested